Devasagayam Sharon, Wyatt Ben, Leyden James, Kleinig Timothy
From the Intensive Care Department, Royal Adelaide Hospital, Adelaide, SA, Australia (S.D.); Emergency Department, Flinders Medical Centre, Bedford Park, SA, Australia (B.W.); Neurology Department, Lyell McEwin Hospital, Elizabeth Vale, SA, Australia (J.L.); Neurology Department, Royal Adelaide, Lyell MCEwin Hospitals (T.K.); and Department of Medicine, University of Adelaide, Adelaide, SA, Australia (T.K.).
Stroke. 2016 Sep;47(9):2180-2. doi: 10.1161/STROKEAHA.116.013617. Epub 2016 Jul 19.
The incidence of cerebral venous thrombosis (CVT) varies between studies, but it is estimated to be between 2 and 5 per million per year. A recent study in the Netherlands with comprehensive ascertainment suggested a much higher incidence. It is uncertain whether these differing estimates reflect the quality of ascertainment or true variation. The purpose of this study was to determine the incidence of CVT in Adelaide, using a novel clinical and radiological methodology.
We retrospectively identified CVT International Classification of Diseases-coded cases from all Adelaide public hospitals from 2005 to 2011. We also searched all neuroimaging studies (259 101) from these hospitals for text variations containing venous thromb. All potential cases were reviewed, and cases of incident CVT ascertained. Associations and outcomes were determined.
Of 169 possible cases, 105 cases of CVT were confirmed (59 cases by both coding and neuroimaging, 40 from neuroimaging alone, and 6 from coding alone). In our population of 953 390 adults, this represented an incidence of 15.7 million per year (95% confidence interval, 12.9-19.0), the highest incidence reported. Of these cases, a possible procoagulant predisposition was identified in 48%. Fifty-five of 105 cases occurred in females. Relative risk of CVT in females of reproductive age was insignificantly higher than in males (1.18 [95% confidence interval, 0.94-1.48]).
Cerebral venous sinus thrombosis in our study was more common than previously reported, perhaps because of more complete ascertainment. Future CVT incidence studies should include comprehensive capture and review of neuroimaging.
脑静脉血栓形成(CVT)的发病率在不同研究中有所差异,但估计每年每百万人口中为2至5例。荷兰近期一项进行全面确诊的研究表明发病率要高得多。这些不同的估计是否反映了确诊质量或真实差异尚不确定。本研究的目的是采用一种新颖的临床和放射学方法来确定阿德莱德CVT的发病率。
我们回顾性地从2005年至2011年阿德莱德所有公立医院中识别出按国际疾病分类编码的CVT病例。我们还在这些医院的所有神经影像学研究(259101项)中搜索包含静脉血栓形成的文本变体。对所有可能的病例进行了审查,并确定了新发CVT病例。确定了相关性和结局。
在169例可能的病例中,确诊了105例CVT(59例通过编码和神经影像学确诊,40例仅通过神经影像学确诊,6例仅通过编码确诊)。在我们953390名成年人的人群中,这代表每年发病率为15.7/百万(95%置信区间,12.9 - 19.0),是报告的最高发病率。在这些病例中,48%发现了可能的促凝倾向。105例病例中有55例发生在女性。育龄女性CVT的相对风险略高于男性,但无统计学意义(1.18[95%置信区间,0.94 - 1.48])。
我们研究中的脑静脉窦血栓形成比以前报道的更常见,可能是因为确诊更全面。未来CVT发病率研究应包括对神经影像学的全面采集和审查。